Forensic Genomics Market By Product Type ( Kits & Assays { DNA Extraction Kits, DNA Amplification Kits, DNA Quantification Kits, STR Kits, mt DNA Kits}, Instrument {Genetic Analyzers, Real-Time PCR Systems, NGS Platforms, Capillary Electrophoresis Systems}, Software and Services {Data Analysis Software, Forensic Databases, DNA Testing Services}), By Technology (Polymerase Chain Reaction, Short Tandem Repeat Analysis, Next-Generation Sequencing (NGS), Capillary Electrophoresis, Microarrays, Other), By Application (Criminal Investigations, Paternity and Relationship Testing, Human Identification, Ancestry and Genealogy Studies, Drug and Alcohol Testing, Other), By End-User (Law Enforcement Agencies, Forensic Laboratories, Academic and Research Institutions, Private Companies, Government Agencies), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Forensic Genomics market accounted for USD 0.65 Billion in 2024 and is expected to reach USD 2.83 Billion by 2035, growing at a CAGR of around 14.3% between 2025 and 2035. The Forensic Genomics Market utilizes genomic measurements including DNA sequencing and bioinformatics applications in examining criminal offenses and legal systems. This market includes the technology and services that allow forensic scientists to collect, process, and interpret genetic data to solve crimes, identify people, and free the innocent.

This market is expected to advance with the help of popular DNA sequencing, integration of artificial intelligence, expanding the scope of forensic genomics beyond the law enforcement industry, etc. Since the advent of forensic genomics technologies and their subsequent development, they have become more and more important in justice systems around the world.

Report Scope:

Market Dynamics

Growing demand for reliable forensic evidence in criminal justice systems globally

The increase in the requirements for accurate and precise forensic data for criminal investigation is constraining the development of the forensic genomics market fundamentally and altering the procedure of crime investigation and judiciary systems in many countries. This market is based on improvements in DNA analysis technologies, which facilitate proficient identification of an individual or solving intricate cases. As one of the most important components of contemporary forensic technologies, such tools are gradually being supplemented with artificial intelligence and machine learning, which not only increases the speed of data analysis but also improves the quality of interpretation.

Governments and international organizations are putting a lot of effort and money into developing infrastructure for expanding the scope and capacity of forensic genomics. Though there are factors such as data security and limited accessibility in the developing world, the forensic genomics market has a clear uphill trajectory due to its position as a key filler of justice systems’ gaps globally.

 Advancements in DNA sequencing and bioinformatics enhancing forensic investigation capabilities

Dramatic improvements are being witnessed in the forensic genomics market due to the introduction of the latest technology such as DNA sequencing as well as bioinformatics. Newer technologies such as NGS solutions have provided forensic experts the ability to work with inferior quality or overlapping DNA samples with incredibly high accuracy, thus improving the ability of its practitioners to identify and apprehend criminal suspects. Modern software tools help auto-classify huge datasets, discover markers for genetic epidemiology, and match evidence more proficiently.

These advancements, AI & ML, enhance pattern recognition along with data interpretation to make the flow faster and decrease the analysis time. Such are not only helping build the Forensic Genomics Market but also solving issues about the identification of victims in mass disasters or assigning cold cases. With progress in technologies, they are expected to revolutionize the market again and strengthen the role of the market in enhancing global justice systems.

High costs of sequencing technologies limiting widespread adoption in developing countries

Currently, Sequencing costs also act as a major constraint to the development of the forensic genomics market especially in the developing world. While NGS and related tools are promising, they are capital-intensive in terms of required equipment and supplies and technical infrastructure, thereby limiting their availability to low-resource nations. This financial barrier limits the use of new forensic genomic methods, furthering justice dysfunctions worldwide.

In many such LRCs, basic investment in infrastructure tends to dominate, obliterating investments in forensic capacity. Yet, with limited funding from the government and international aid organizations acquiring such technologies is almost impossible. Underscoring this challenge calls for a reduction of cost through innovation, global partnerships, and real, affordable solutions that will transform the Forensic Genomics Market to be accessible and meaningful across the world.

Increasing use of forensic genomics in non-criminal applications like ancestry research

The rising applications of forensic genomics in non-forensic activities like ancestry research are thus rapidly growing the market space of forensic genomics. Molecular technologies that are used in forensics, initially, are also being used to study deep familiar relationships and help to find people’s relatives. Mainstream firms such as AncestryDNA have led this change by providing genealogical testing services that are performed using the same powerful forensic-­grade genomic tools.

This trend not only expanded the use of forensic genomics but also helped to make an addition to this market since it targeted buyers’ demand to obtain personal genetic data. When more people show interest in knowing more about their ancestry, preferences, or medical predispositions, tech companies fill this need hence evolving genetic testing services and the forensic genomics market. The realization of these technologies in personal genealogy services shows applications of forensic science in unrelated, individual roles, expanding the future of genetic studies even more.

Integration of AI and machine learning improving forensic genomics data analysis

There is a growing acceptance of the application of AI and machine learning in the Forensic Genomics Market which is positively impacting data analysis. Such technologies accelerate the analysis and interpretation of intricate data on genomes making the forensic study more accurate. Today, it is possible to develop algorithms that recognize genetic patterns and abnormalities with high accuracy due to their potential for minimizing the human factor and the time needed to analyze an array of data. Machine learning models are also being developed for predicting the degree of relatedness between the genomes, and for enhanced recovery of the DNA match for the case when the samples are degraded or contain only fragments.

The use of AI in bioinformatics is assisting forensic professionals to make on-the-spot decisions during investigations to bring quick ends to criminal cases. In addition to enhancing the performance of forensic genomics, AI and machine learning also help expand the market through enhanced efficiency of the process with non-repetitive and more accurate methods. This integration is important because soon forensic science is going to rely more on rapid data analysis in criminal justice as well as in public safety.

Industry Experts Opinion

“The power of genomics to serve the forensic market while improving justice and public safety provides a strong case for the need to address remaining barriers to NGS adoption in crime laboratories as quickly as possible.”

•  Paul Grossman, Venture Partner, THP

“Verogen will build on Illumina’s past efforts by focusing on innovation, development, and commercialization of forensic genomics products, built on a deep understanding of how to improve the science behind the use of genetic data in matters of justice.”

•  Dawn Barry, Vice President, Illumina. 

Segment Analysis

Based on Technology, the Forensic Genomics Market includes Polymerase Chain Reaction (PCR), Short Tandem Repeat (STR) Analysis, Next-Generation Sequencing (NGS), Capillary Electrophoresis, Microarrays, and others. PCR and STR analysis are chosen due to the accuracy and efficiency proved in DNA amplification and profiling. PCR is an excellent foundation for forensic DNA analysis, it is fast and accurate, and works well on degraded samples; STR analysis provides absolute identification due to specific DNA loci. It is taken further by the rising usage of NGS in the market since it enhances the complete DNA sequencing necessary for sorting out intricate issues. In addition, foreseen development of capillary electrophoresis and microarray technologies broadens the use of forensic genomics, where governments boost funding for forensic improvement.

Based on Application, the Forensic Genomics Market is classified into criminality, paternity and relationship, identity, ancestry & lineage, substance abuse, and other applications. Criminal investigations most significantly contribute to this segment as increasing demand for reliable and efficient identification for solving crimes and unsolved cases. Biometric identification applications are also increasing because of the vital role they play in mass disaster victim identification and missing persons cases. At the same time, the use of paternity and relationship testing is gradually growing due to Society’s awareness of the existence of genetic links. Hereditary and origin research markets are still rapidly developing, being stimulated by people’s desire to know more about their family trees. Such applications are backed up by technology to offer proper measures and trusted outcomes collectively propelling the market ahead.

Regional Analysis

North America is the largest growing region in the forensic genomics market because of advanced technologies, more funding in forensic science, and higher crime-solving rates. The top countries with intensive usage of both NGS equipment and DNA profile advances in the United States, which has federally backed initiatives such as CODIS (Combined DNA Index System). Recent innovations in technology include the use of AI for fast DNA analysis and the use of cloud solutions for secure storage of data. This region also raises dynamic partnerships between universities and law enforcement to advance developments such as genetic genealogy and phenotypic prediction. These collaborations help the region maintain its status as the world's leader in forensic genomics production.

Asia-Pacific is the fastest-growing region in the forensic genomics market, because of advancing technologies and increasing demand for solving crimes in rapidly developing countries such as China and India. More specifically, the governments in this region are investing in improving the forensic genomic centers equipped with the updated DNA sequencing technology and embarking on the process of creating new databases for use in criminal cases. Current advancements like on-site DNA sequencing devices and AI-based predictive modeling are catching the eye. Public-private collaborations and educational programs designed to produce qualified forensic professionals are key factors driving the growth of this market.

Competitive Landscape

The Forensic Genomics Market is competitive owing to scientific improvements in sequencing and genetic analysis. Thermo Fisher Scientific, Qiagen, Illumina, and Promega Corporation, these companies dominate due to their production strength and rich product portfolios. Thermo Fisher uses its broad sequencing systems such as Ion Torrent for fast and accurate forensic applications, on the other hand, Qiagen provides Kits and reagents for nucleic acid purification and is designed for degraded samples applications.

Illumina focuses on innovation in high-throughput sequencing, helping in getting quicker solutions at crime scenes. Their specialty includes STR kits which are essential for identity purposes. New entrants are coming up in the market offering highly innovative next-generation sequencing (NGS) products that specifically target forensic laboratories most companies also focus on partnerships with police and academic institutions to improve products phenotypic prediction and familial searches so that their product is cutting edge in forensic use.

Forensic Genomics Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In November 2024, Qiagen, announced the launch of two new tools for designing and ordering custom solutions that can be used to support microbial analysis of bacterial, fungal, and viral targets. These new tools enable researchers to customize their assays and panels for use on the QIAcuity digital PCR system as well as on any third-party next-generation sequencing (NGS) system. The new products make nanoplate digital PCR (dPCR) suitable for even more microbial targets in applications ranging from wastewater testing to food production to analysis of human pathogens.
• In November 2024, Illumina raised the curtain on a revamp of its flagship tumor profiling test, which aims to offer faster turnarounds, fewer materials, and fuller coverage of difficult genomic regions to help identify rare cancer biomarkers. Version 2 of the TruSight Oncology 500 tissue research-use-only assay is currently under development, the company said, with a global release set for mid-2025.

Report Coverage:

By Product Type

• Kits & Assays
  • DNA Extraction Kits
  • DNA Amplification Kits
  • DNA Quantification Kits
  • STR Kits (Short Tandem Repeat)
  • mtDNA Kits (Mitochondrial DNA)
• Instruments
  • Genetic Analyzers
  • Real-Time PCR Systems
  • NGS Platforms
  • Capillary Electrophoresis Systems
• Software and Services
  • Data Analysis Software
  • Forensic Databases
  • DNA Testing Services

By Technology

• Polymerase Chain Reaction (PCR)
• Short Tandem Repeat (STR) Analysis
• Next-Generation Sequencing (NGS)
• Capillary Electrophoresis
• Microarrays
• Other

By Application

• Criminal Investigations
• Paternity and Relationship Testing
• Human Identification
• Ancestry and Genealogy Studies
• Drug and Alcohol Testing
• Other

By End User

• Law Enforcement Agencies
• Forensic Laboratories
• Academic and Research Institutions
• Private Companies
• Government Agencies

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Thermo Fisher Scientific
• QIAGEN
• Illumina, Inc.
• Agilent Technologies
• Promega Corporation
• PerkinElmer, Inc.
• Eurofins Scientific
• LGC Biosearch Technologies
• Gene By Gene, Ltd.
• Verogen, Inc.
• Bode Technology Group, Inc.
• Parabon NanoLabs, Inc.
• NicheVision Forensics, LLC
• Theragen Bio
• PathogenDx, Inc.
• Nucleome Informatics
• Heterogeneous Bioinformatics Pvt. Ltd.
• DNAnexus, Inc.

Frequently Asked Questions (FAQs)